Literature DB >> 18181172

Ets-1 triggers and orchestrates the malignant phenotype of mammary cancer cells within their matrix environment.

Alessandro Furlan1, Chantal Vercamer, Xavier Desbiens, Albin Pourtier.   

Abstract

Acquisition of invasive characteristics is a hallmark of breast carcinoma progression. During this phenomenon, Ets-1 transcription factor overexpression is induced and associated with breast cancer invasiveness, and poor prognosis. We hypothesized that Ets-1 transcription factor could be the orchestrator of a genetic program inducing the expression of genes necessary for cell motility, as postulated by the tumor microenvironment invasion model. We aimed at elucidating the role of Ets-1 in the molecular control of mammary cancer cell invasion and aggressiveness within their matrix environment. To that purpose, mouse mammary tumor MMT epithelial cells were engineered to stably overexpress Ets-1, or the dominant negative Ets-1 DNA Binding domain. The biological function of Ets-1 was assessed in three-dimensional extracellular matrix systems recreating a microenvironmental architecture resembling in vivo geometric constraints. Ets-1 overexpression provided MMT cells with a motile and invasive phenotype, leading to cell scattering, and impairing multicellular organization in matrix-mimicking gels. We evidenced that Ets-1 promoted HGF/SF activation, and the expression of its receptor, c-Met. Ets-1 also orchestrated switches in integrin expression pattern, towards a pro-migratory and malignant phenotype. Moreover, Ets-1 concomitantly triggered matrix metalloproteinases (MMP) expression and activation, thus contributing to cell scattering. Functional relevance of these observations was confirmed with blocking antibodies or MMP inhibitors. Our data highlight a critical role for Ets-1 in the orchestration of a network of molecular and phenotypic events, converging to enhance malignant features and invasion by mammary cancer cells of their environment. Ets-1 overexpression hence appears as a probable key step for breast cancer progression. (c) 2008 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18181172     DOI: 10.1002/jcp.21360

Source DB:  PubMed          Journal:  J Cell Physiol        ISSN: 0021-9541            Impact factor:   6.384


  14 in total

1.  The Influence of Biomaterials on Cytokine Production in 3D Cultures.

Authors:  Mary C Regier; Sara I Montanez-Sauri; Michael P Schwartz; William L Murphy; David J Beebe; Kyung Eun Sung
Journal:  Biomacromolecules       Date:  2017-02-16       Impact factor: 6.988

Review 2.  MiR-145: a potential biomarker of cancer migration and invasion.

Authors:  Wen-Xiu Xu; Zhen Liu; Fei Deng; Dan-Dan Wang; Xing-Wang Li; Tian Tian; Jian Zhang; Jin-Hai Tang
Journal:  Am J Transl Res       Date:  2019-11-15       Impact factor: 4.060

Review 3.  Multiple roles of CD90 in cancer.

Authors:  Atul Kumar; Anshuman Bhanja; Jina Bhattacharyya; Bithiah Grace Jaganathan
Journal:  Tumour Biol       Date:  2016-06-23

Review 4.  Implications of miR cluster 143/145 as universal anti-oncomiRs and their dysregulation during tumorigenesis.

Authors:  Ani V Das; Radhakrishna M Pillai
Journal:  Cancer Cell Int       Date:  2015-09-29       Impact factor: 5.722

5.  Ets-1 is a transcriptional mediator of oncogenic nitric oxide signaling in estrogen receptor-negative breast cancer.

Authors:  Christopher H Switzer; Robert Y-S Cheng; Lisa A Ridnour; Sharon A Glynn; Stefan Ambs; David A Wink
Journal:  Breast Cancer Res       Date:  2012-09-12       Impact factor: 6.466

6.  Senescent fibroblasts enhance early skin carcinogenic events via a paracrine MMP-PAR-1 axis.

Authors:  Nicolas Malaquin; Chantal Vercamer; Fatima Bouali; Sébastien Martien; Emeric Deruy; Nicolas Wernert; Maggy Chwastyniak; Florence Pinet; Corinne Abbadie; Albin Pourtier
Journal:  PLoS One       Date:  2013-05-10       Impact factor: 3.240

7.  Inhibitory effect of HGF on invasiveness of aggressive MDA-MB231 breast carcinoma cells, and role of HDACs.

Authors:  E Ridolfi; E Matteucci; P Maroni; M A Desiderio
Journal:  Br J Cancer       Date:  2008-10-21       Impact factor: 7.640

8.  Regulation of p110delta PI 3-kinase gene expression.

Authors:  Klaartje Kok; Gemma E Nock; Elizabeth A G Verrall; Michael P Mitchell; Daan W Hommes; Maikel P Peppelenbosch; Bart Vanhaesebroeck
Journal:  PLoS One       Date:  2009-04-09       Impact factor: 3.240

9.  The breast cancer oncogene EMSY represses transcription of antimetastatic microRNA miR-31.

Authors:  Emmanuelle Viré; Christina Curtis; Veronica Davalos; Anna Git; Samuel Robson; Alberto Villanueva; August Vidal; Isaia Barbieri; Samuel Aparicio; Manel Esteller; Carlos Caldas; Tony Kouzarides
Journal:  Mol Cell       Date:  2014-02-27       Impact factor: 17.970

10.  ESE-1/ELF3 mRNA expression associates with poor survival outcomes in HER2+ breast cancer patients and is critical for tumorigenesis in HER2+ breast cancer cells.

Authors:  Adwitiya Kar; Arthur Gutierrez-Hartmann
Journal:  Oncotarget       Date:  2017-06-27
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.